An Elevation of Serum Ferritin Level Might Increase Clinical Risk for the Persistence of Patent Ductus Arteriosus, Sepsis and Bronchopulmonary Dysplasia in Erythropoietin-Treated Very-Low-Birth-Weight Infants
An Elevation of Serum Ferritin Level Might Increase Clinical Risk for the Persistence of Patent Ductus Arteriosus, Sepsis and Bronchopulmonary Dysplasia in Erythropoietin-Treated Very-Low-Birth-Weight Infants
复制标题
DOI:
10.1159/000447991
复制
发表时间:
2017-01-01
期刊:
影响因子:
2.5
通讯作者:
Takada, Hidetoshi
中科院分区:
文献类型:
--
作者:
Ochiai, Masayuki;Kurata, Hiroaki;Takada, Hidetoshi
Background:The substantial risk of iron overload is not routinely monitored in most of the neonatal intensive care units (NICUs) in Japan; however, blood transfusion is an essential strategy for successfully treating preterm low-birth-weight infants, Objective: The aim of this study was to investigate the iron status and clinical features of infants with a birth weight of